Jericho Sciences, LLC
Biotech · Private
Small molecule therapeutic targeting Hepatitis B X protein (HBx) to eliminate persistent viral cccDNA and cure chronic HBV infection
jerichosciences.com →- Grants
- $3.2M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 3
- 0 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201620182020202220242026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Standardizable Whole Blood Culture for Evaluating HIV Eradication Strategies | $416,402 | |
| Federal grant | Department of Health and Human Services · Phase II · Safety and Efficacy Testing of FX101 in an SIV/NHP Model | $1,792,335 | |
| Federal grant | Department of Health and Human Services · Phase II · Safety and Efficacy Testing of FX101 in an SIV/NHP Model | $637,692 | |
| Federal grant | Department of Health and Human Services · Phase I · Translational Development of a Small Molecule for the Treatment of HBV Infection | $320,863 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1429 | IMAGINEERING TECHNOLOGIES INC | — | $14M |
| 1430 | Akanocure Pharmaceuticals, Inc. | — | $1.0M |
| 1431 | IT Bio, LLC | — | — |
| 1432 | Jericho Sciences, LLC | — | — |
| 1433 | Starwise Therapeutics LLC | — | — |
| 1434 | ALLYX THERAPEUTICS INC | — | $40M |
| 1435 | BIOLIFE SOLUTIONS INC | — | $10M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Treating Lentivirus Infectionapplication
- Methods For Viral Infectionsapplication
- Methods For Treating Lentivirus Infectionapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.